Current perspective in tuberculosis vaccine development for high TB endemic regions - 09/05/16
Summary |
Tuberculosis (TB) continues to be a global epidemic, despite of the availability of Bacillus Calmette Guerin (BCG) vaccine for more than six decades. In an effort to eradicate TB, vaccinologist around the world have made considerable efforts to develop improved vaccine candidates, based on the understanding of BCG failure in developing world and immune response thought to be protective against TB. The present review represents a current perspective on TB vaccination research, including additional research strategies needed for increasing the efficacy of BCG, and for the development of new effective vaccines for high TB endemic regions.
Le texte complet de cet article est disponible en PDF.Keywords : BCG, T cell, Biomarkers, Vaccine, Endemic regions
Abbreviations : TB, Mtb, WHO, BCG, TST, PPD, LTBI, Th1, Th2, Tregs, TGF-β, IFN-γ, IL-12, IL-17, TNF-α, PBMCs, TBM, CNS
Plan
Vol 98
P. 149-158 - mai 2016 Retour au numéro
Article précédent
- Strategies of genome editing in mycobacteria: Achievements and challenges
- Eira Choudhary, Ajitesh Lunge, Nisheeth Agarwal
- Cloning, expression and characterization of histidine-tagged biotin synthase of Mycobacterium tuberculosis
- Clement Chedza Magwamba, Kamolchanok Rukseree, Prasit Palittapongarnpim
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?